IDYA
Price
$25.93
Change
+$0.01 (+0.04%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
2.27B
49 days until earnings call
IMTX
Price
$7.12
Change
+$0.27 (+3.94%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
832.68M
56 days until earnings call
Interact to see
Advertisement

IDYA vs IMTX

Header iconIDYA vs IMTX Comparison
Open Charts IDYA vs IMTXBanner chart's image
IDEAYA Biosciences
Price$25.93
Change+$0.01 (+0.04%)
Volume$22.41K
Capitalization2.27B
Immatics
Price$7.12
Change+$0.27 (+3.94%)
Volume$7.74K
Capitalization832.68M
IDYA vs IMTX Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. IMTX commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Buy and IMTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (IDYA: $25.92 vs. IMTX: $6.85)
Brand notoriety: IDYA and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 118% vs. IMTX: 58%
Market capitalization -- IDYA: $2.27B vs. IMTX: $832.68M
IDYA [@Biotechnology] is valued at $2.27B. IMTX’s [@Biotechnology] market capitalization is $832.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.23B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, IMTX is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 6 TA indicator(s) are bullish while IMTX’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 6 bullish, 3 bearish.
  • IMTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than IMTX.

Price Growth

IDYA (@Biotechnology) experienced а +5.67% price change this week, while IMTX (@Biotechnology) price change was +20.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.94%. For the same industry, the average monthly price growth was +8.31%, and the average quarterly price growth was +48.45%.

Reported Earning Dates

IDYA is expected to report earnings on Nov 11, 2025.

IMTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.27B) has a higher market cap than IMTX($833M). IDYA YTD gains are higher at: 0.856 vs. IMTX (-3.657). IMTX has higher annual earnings (EBITDA): -58.05M vs. IDYA (-380.2M). IDYA has more cash in the bank: 670M vs. IMTX (478M). IMTX has less debt than IDYA: IMTX (17.1M) vs IDYA (26.6M). IMTX has higher revenues than IDYA: IMTX (130M) vs IDYA (7M).
IDYAIMTXIDYA / IMTX
Capitalization2.27B833M273%
EBITDA-380.2M-58.05M655%
Gain YTD0.856-3.657-23%
P/E RatioN/A29.35-
Revenue7M130M5%
Total Cash670M478M140%
Total Debt26.6M17.1M156%
FUNDAMENTALS RATINGS
IDYA vs IMTX: Fundamental Ratings
IDYA
IMTX
OUTLOOK RATING
1..100
8019
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
58
Fair valued
PROFIT vs RISK RATING
1..100
68100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
4846
P/E GROWTH RATING
1..100
10052
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMTX's Valuation (58) in the null industry is in the same range as IDYA (61). This means that IMTX’s stock grew similarly to IDYA’s over the last 12 months.

IDYA's Profit vs Risk Rating (68) in the null industry is in the same range as IMTX (100). This means that IDYA’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's SMR Rating (95) in the null industry is in the same range as IDYA (97). This means that IMTX’s stock grew similarly to IDYA’s over the last 12 months.

IMTX's Price Growth Rating (46) in the null industry is in the same range as IDYA (48). This means that IMTX’s stock grew similarly to IDYA’s over the last 12 months.

IMTX's P/E Growth Rating (52) in the null industry is somewhat better than the same rating for IDYA (100). This means that IMTX’s stock grew somewhat faster than IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYAIMTX
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 19 days ago
77%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
77%
Bearish Trend 9 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGXRX17.230.04
+0.23%
Hartford Global Impact R3
APDGX27.540.05
+0.18%
Artisan Global Value Advisor
PAULX45.730.07
+0.15%
T. Rowe Price US Large-Cap Core Adv
SECUX38.900.02
+0.05%
NAA Mid Growth A
SMDVX18.580.01
+0.05%
Hartford Schroders US MidCap Opps A

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+0.70%
IMNM - IDYA
60%
Loosely correlated
+4.05%
SYRE - IDYA
59%
Loosely correlated
+2.76%
NRIX - IDYA
58%
Loosely correlated
-0.12%
CGON - IDYA
57%
Loosely correlated
+0.38%
CRNX - IDYA
57%
Loosely correlated
-0.56%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+2.24%
IDYA - IMTX
52%
Loosely correlated
+0.70%
OCUL - IMTX
51%
Loosely correlated
+0.83%
CRNX - IMTX
49%
Loosely correlated
-0.56%
IMVT - IMTX
48%
Loosely correlated
+5.48%
XNCR - IMTX
48%
Loosely correlated
+0.97%
More